ArticleFrontiers in oncology2022

First-Line Tyrosine Kinase Inhibitors Combined With Local Consolidative Radiation Therapy for Elderly Patients With Oligometastatic Non-Small Cell Lung Cancer Harboring EGFR Activating Mutations.

Xiaolong Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.